Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism TXNIP inhibitors(thioredoxin interacting protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 15 Aug 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 15 Aug 2025 | |
| Functional disorder | Discovery | - | 15 Aug 2025 | |
| Kidney Diseases | Discovery | - | 15 Aug 2025 | |
| Metabolic dysfunction-associated steatotic liver disease | Discovery | - | 15 Aug 2025 | |
| Neuritis | Discovery | - | 15 Aug 2025 | |
| Retinitis | Discovery | - | 15 Aug 2025 |





